Publication & Citation Trends
Publications
0 total
PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial
Cited by 34
Semantic Scholar
Phase I study on preliminary safety and efficacy of rovalpituzumab tesirine in Japanese patients (pts) with advanced, recurrent small cell lung cancer (SCLC).
Cited by 2
Semantic Scholar
Ph1/2 study of Rova-T in combination with nivolumab (Nivo) ± ipilimumab (Ipi) for patients (pts) with 2L+ extensive-stage (ED) SCLC.
Cited by 12
Semantic Scholar
Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer.
Cited by 27
Semantic Scholar
Abstract 4227: Treatment regimens, treatment duration, and between-treatment duration in patients with small cell lung cancer across lines of therapy: An analysis of electronic health records data
Cited by 0
Semantic Scholar
Phase 1 study on safety and PK of rovalpituzumab tesirine (Rova-T) in Japanese patients with advanced, recurrent SCLC. OA
Cited by 0
Semantic Scholar
1536TiPAn open-label study on safety and tolerability of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer OA
Cited by 1
Semantic Scholar
1538TiPA phase 1/2 study on safety of rovalpituzumab tesirine in combination with nivolumab or nivolumab + ipilimumab in small cell lung cancer OA
Cited by 2
Semantic Scholar
Research Topics
Cancer Treatment and Pharmacology
(10)
Lung Cancer Research Studies
(7)
Pharmacogenetics and Drug Metabolism
(5)
Prostate Cancer Treatment and Research
(4)
Cancer therapeutics and mechanisms
(4)
Affiliations
University of North Carolina at Chapel Hill
Children's Mercy Hospital
American Pharmacists Association
AbbVie (United States)
University of Chicago